论文部分内容阅读
本文分析了316例各型再生障碍性贫血(以下简称再障)的治疗结果。全部病人分为5组:第1组,78例,仅用输血治疗:第2组,48例,用输血和强的松治疗;第3、4组,除上述治疗方法外,还用同种骨髓移植(第3组,76例)和切脾(第4组,74例);第5组,68例,用上述方法综合治疗。再障的类型分为:亚急性再障、再障、再障合并血管内溶血,慢性再障和部分再障(保存血小板生成)5类。疗效结果分为缓解、改善和死亡。至少一年不需经任何治疗血红蛋白保持在9～10克％,白细胞和血小板数目周期性达到正常为缓解;如需周期性输血才能维持血红蛋白在8～10克％,白细胞和血小
This article analyzes the treatment of 316 cases of various types of aplastic anemia (hereinafter referred to as aplastic anemia). All patients were divided into 5 groups: group 1, 78 cases, only transfusion: group 2, 48 cases, with blood transfusion and prednisone treatment; 3,4 groups, in addition to the above treatment, but also with the same Bone marrow transplantation (group 3, 76 cases) and splenectomy (group 4, 74 cases); Group 5, 68 cases, combined treatment with the above method. Aplastic anemia types are: subacute aplastic anemia, aplastic anemia, aplastic anemia with intravascular hemolysis, chronic aplastic anemia and partial aplastic (preservation of platelet production) 5 categories. Efficacy results divided into mitigation, improvement and death. At least one year without any treatment of hemoglobin remained at 9 to 10 grams%, the number of white blood cells and platelets to reach normal for the remission; for periodic blood transfusion in order to maintain hemoglobin in 8 to 10%, white blood cells and blood